Milind Deora joins Shashi Tharoor and Jairam Ramesh in questioning ‘premature approval’ for Bharat Biotech’s Covaxin even though the Congress has officially welcomed the vaccine.
Dharmendra Pradhan's remarks came after Congress leaders raised doubts on the approval of Bharat Biotech's vaccine, for restricted use, while its 3rd phase trial is still underway.
Samajwadi Party chief Akhilesh Yadav erred big time with his ‘BJP’s vaccine’ comment. But it highlights how BJP is winning the battle of public perception in Covid management.
Congress’ Anand Sharma, head of parliamentary panel, says health ministry needs to explain sidestepping protocol because Covaxin will be given to frontline workers.
In an interview, ICMR chief Balram Bhargava addressed questions that have been raised about the approval granted to Covaxin in the absence of efficacy data.
Drugs Controller General of India has granted 'conditional approval' to the vaccine candidates. A third candidate by Cadila Healthcare has got nod to conduct Phase III clinical trial.
Covaxin has been recommended for restricted emergency use authorisation by a subject expert committee appointed by the Central Drugs Standard Control Organisation.
Bharat Biotech's Covaxin has been recommended for restricted emergency use authorisation by an expert committee appointed by the Central Drugs Standard Control Organisation.
Mamdani’s politics feels unusual compared to India’s current climate. He unapologetically foregrounds Muslim identity at a time when doing so in India invites scrutiny.
On 4 November 2025, NCLAT bench, comprising Chairperson Justice Ashok Bhushan and Member Arun Baroka, noted that WhatsApp and Meta are distinct legal entities.
This world is being restructured and redrawn by one man, and what’s his power? It’s not his formidable military. It’s trade. With China, it turned on him.
COMMENTS